docruДоктор.РуTitle1727-23782713-2994ООО "ГК "РУСМЕДИКАЛ"10.31550/1727-2378-2023-22-6-44-48docru-259Research ArticleПСИХИАТРИЯPSYCHIATRYДепрессивные расстройства у лиц, перенесших COVID-19: клиническое наблюдениеDepressive Disorders in Survivors of COVID-19: Clinical Observationhttps://orcid.org/0000-0002-9754-8720ГоловкинаД. А.GolovkinaD. A.

Головкина Дарья Андреевна — ассистент кафедры психиатрии и наркологии 

119021, г. Москва, ул. Россолимо, д. 11, стр. 9 

11 Rossolimo Str., build. 11, Moscow, 119021 

golovkina_d_a@staff.sechenov.ruhttps://orcid.org/0000-0002-3457-5123ВасютаА. К.VasyutaA. K.

Васюта Анастасия Константиновна — аспирант кафедры психиатрии и наркологии 

119021, г. Москва, ул. Россолимо, д. 11, стр. 9 

11 Rossolimo Str., build. 11, Moscow, 119021 

vasyuta_nastya@icloud.comhttps://orcid.org/0000-0001-6071-2796ТихоноваЮ. Г.TikhonovaYu. G.

Тихонова Юлия Гулямовна — д. м. н., профессор кафедры психиатрии и наркологии 

119021, г. Москва, ул. Россолимо, д. 11, стр. 9 

11 Rossolimo Str., build. 11, Moscow, 119021 

tikhonova_yu_g@staff.sechenov.ruhttps://orcid.org/0000-0002-5109-1438АвдееваТ. И.AvdeevaT. I.

Авдеева Татьяна Ивановна — д. м. н., профессор кафедры психиатрии и наркологии 

119021, г. Москва, ул. Россолимо, д. 11, стр. 9 

11 Rossolimo Str., build. 11, Moscow, 119021 

avdeeva_t_i@staff.sechenov.ruhttps://orcid.org/0000-0001-8386-758XКинкулькинаМ. А.KinkulkinaM. A.

Кинкулькина Марина Аркадьевна — член-корреспондент РАН, д. м. н., профессор, заведующая кафедрой психиатрии и наркологии 

119021, г. Москва, ул. Россолимо, д. 11, стр. 9 

11 Rossolimo Str., build. 11, Moscow, 119021 

kinkulkina_m_a@staff.sechenov.ruФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University (Sechenov University)Russian Federation202319022025226НЕВРОЛОГИЯ ПСИХИАТРИЯ4448Copyright © Головкина Д.А., Васюта А.К., Тихонова Ю.Г., Авдеева Т.И., Кинкулькина М.А., 20252025Головкина Д.А., Васюта А.К., Тихонова Ю.Г., Авдеева Т.И., Кинкулькина М.А.Golovkina D.A., Vasyuta A.K., Tikhonova Y.G., Avdeeva T.I., Kinkulkina M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://docru.elpub.ru/jour/article/view/259Цель статьи

Цель статьи: представить клиническое наблюдение пациента С., впервые обратившегося в психиатрическую клинику в связи с развитием у него депрессивного эпизода после перенесенной инфекции COVID-19.

Основные положения

Основные положения. После перенесенного COVID-19 возможно появление различных осложнений, которые длятся от нескольких недель до нескольких месяцев после первоначального выздоровления. У молодых ранее здоровых людей постковидные нарушения могут возникать даже после легкого течения COVID-19. Одно из последствий перенесенной коронавирусной инфекции — депрессивные и тревожные расстройства.

Заключение

Заключение. Данный клинический случай демонстрирует, что в постковидном периоде развиваются стойкие депрессивные расстройства, приводящие к дезадаптации пациента и требующие психофармакотерапевтического вмешательства.

Aim

Aim: To present a case study of patient S., who came to the psychiatric clinic because of a depressive episode after COVID-19 infection.

Key points

Key points. COVID-19 can cause various complications that last several weeks to several months after initial recovery. Young, healthy individuals can have post-COVID disorders even after mild COVID-19. Depression and anxiety disorders are among the consequences of past coronavirus infection.

Conclusion

Conclusion. This case study demonstrates that post-COVID patients develop persistent depres-sive disorders causing patient maladaptation and requiring drug therapy.

COVID-19состояние после COVID-19депрессивное расстройствотревожное расстройствоCOVID-19post-COVID-19 conditiondepressive disorderanxiety disorderReferencesDatta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251–2. DOI: 10.1001/jama.2020.22717Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251–2. DOI: 10.1001/jama.2020.22717Greenhalgh T., Knight M., A'Court C., Buxton M. et al. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. DOI: 10.1136/bmj.m3026Greenhalgh T., Knight M., A'Court C., Buxton M. et al. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. DOI: 10.1136/bmj.m3026Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D. et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect. Dis. 2021;8(10):ofab440. DOI: 10.1093/ofid/ofab440Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D. et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect. Dis. 2021;8(10):ofab440. DOI: 10.1093/ofid/ofab440Hampshire A., Trender W., Chamberlain S.R., Jolly A.E. et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. DOI: 10.1016/j.eclinm.2021.101044Hampshire A., Trender W., Chamberlain S.R., Jolly A.E. et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. DOI: 10.1016/j.eclinm.2021.101044Hellmuth J., Barnett T.A., Asken B.M., Kelly J.D. et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 2021;27(1):191–5. DOI: 10.1007/s13365- 021-00954-4Hellmuth J., Barnett T.A., Asken B.M., Kelly J.D. et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 2021;27(1):191–5. DOI: 10.1007/s13365- 021-00954-4Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681–702. DOI: 10.1007/s40263-022-00931-3Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681–702. DOI: 10.1007/s40263-022-00931-3Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47(2):232–41. DOI: 10.1002/biof.1726 8. Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16–27.e1. DOI: 10.1016/j.cell.2020.08.028Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47(2):232–41. DOI: 10.1002/biof.1726 8. Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16–27.e1. DOI: 10.1016/j.cell.2020.08.028Wu Y., Xu X., Chen Z., Duan J. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18–22. DOI: 10.1016/j.bbi.2020.03.031Wu Y., Xu X., Chen Z., Duan J. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18–22. DOI: 10.1016/j.bbi.2020.03.031Ali Awan H., Najmuddin Diwan M., Aamir A., Ali M. et al. SARS-CoV-2 and the brain: what do we know about the causality of 'cognitive COVID? J. Clin. Med. 2021;10(15):3441. DOI: 10.3390/jcm10153441Ali Awan H., Najmuddin Diwan M., Aamir A., Ali M. et al. SARS-CoV-2 and the brain: what do we know about the causality of 'cognitive COVID? J. Clin. Med. 2021;10(15):3441. DOI: 10.3390/jcm10153441Jha N.K., Ojha S., Jha S.K., Dureja H. et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J. Mol. Neurosci. 2021;71(11): 2192–209. DOI: 10.1007/s12031-020-01767-6Jha N.K., Ojha S., Jha S.K., Dureja H. et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J. Mol. Neurosci. 2021;71(11): 2192–209. DOI: 10.1007/s12031-020-01767-6Muccioli L., Pensato U., Cani I., Guarino M. et al. COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation. Ann. Neurol. 2020;88(4):860–1. DOI: 10.1002/ana.25855Muccioli L., Pensato U., Cani I., Guarino M. et al. COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation. Ann. Neurol. 2020;88(4):860–1. DOI: 10.1002/ana.25855Altena E., Baglioni C., Espie C.A., Ellis J. et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy. J. Sleep Res. 2020;29(4):e13052. DOI: 10.1111/jsr.13052Altena E., Baglioni C., Espie C.A., Ellis J. et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy. J. Sleep Res. 2020;29(4):e13052. DOI: 10.1111/jsr.13052Gunaratne P., Lloyd A.R., Vollmer-Conna U. Mood disturbance after infection. Aust. N. Z. J. Psychiatry. 2013;47(12:1152–64. DOI: 10.1177/0004867413503718Gunaratne P., Lloyd A.R., Vollmer-Conna U. Mood disturbance after infection. Aust. N. Z. J. Psychiatry. 2013;47(12:1152–64. DOI: 10.1177/0004867413503718Okusaga O., Yolken R.H., Langenberg P., Lapidus M. et al. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J. Affect. Disord. 2011;130(1– 2):220–5. DOI: 10.1016/j.jad.2010.09.029Okusaga O., Yolken R.H., Langenberg P., Lapidus M. et al. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J. Affect. Disord. 2011;130(1– 2):220–5. DOI: 10.1016/j.jad.2010.09.029Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95– 8. DOI: 10.1093/qjmed/hcab007Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95– 8. DOI: 10.1093/qjmed/hcab007Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav. Immun. 2020;89:531–42. DOI: 10.1016/j.bbi.2020.05.048Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav. Immun. 2020;89:531–42. DOI: 10.1016/j.bbi.2020.05.048Chew N.W.S., Lee G.K.H., Tan B.Y.Q., Jing M. et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav. Immun. 2020;88:559–65. DOI: 10.1016/j.bbi.2020.04.049Chew N.W.S., Lee G.K.H., Tan B.Y.Q., Jing M. et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav. Immun. 2020;88:559–65. DOI: 10.1016/j.bbi.2020.04.049Grover S., Sahoo S., Mishra E., Gill K.S. et al. Fatigue, perceived stigma, self-reported cognitive deficits and psychological morbidity in patients recovered from COVID-19 infection. Asian J. Psychiatr. 2021;64:102815. DOI: 10.1016/j.ajp.2021.102815Grover S., Sahoo S., Mishra E., Gill K.S. et al. Fatigue, perceived stigma, self-reported cognitive deficits and psychological morbidity in patients recovered from COVID-19 infection. Asian J. Psychiatr. 2021;64:102815. DOI: 10.1016/j.ajp.2021.102815Bonazza F., Borghi L., di San Marco E.C., Piscopo K. et al. Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients. Res. Psychother. 2021;23(3):491. DOI: 10.4081/ripppo.2020.491Bonazza F., Borghi L., di San Marco E.C., Piscopo K. et al. Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients. Res. Psychother. 2021;23(3):491. DOI: 10.4081/ripppo.2020.491Castelli L., Di Tella M., Benfante A., Romeo A. The spread of COVID-19 in the Italian population: anxiety, depression, and post-traumatic stress symptoms. Can. J. Psychiatry. 2020;65(10):731–2. DOI: 10.1177/0706743720938598Castelli L., Di Tella M., Benfante A., Romeo A. The spread of COVID-19 in the Italian population: anxiety, depression, and post-traumatic stress symptoms. Can. J. Psychiatry. 2020;65(10):731–2. DOI: 10.1177/0706743720938598Huang L., Yao Q., Gu X., Wang Q. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747–58. DOI: 10.1016/S0140-6736(21)01755-4Huang L., Yao Q., Gu X., Wang Q. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747–58. DOI: 10.1016/S0140-6736(21)01755-4Efstathiou V., Stefanou M.I., Demetriou M., Siafakas N. et al. Long COVID and neuropsychiatric manifestations (review). Exp. Ther. Med. 2022;23(5):363. DOI: 10.3892/etm.2022.11290Efstathiou V., Stefanou M.I., Demetriou M., Siafakas N. et al. Long COVID and neuropsychiatric manifestations (review). Exp. Ther. Med. 2022;23(5):363. DOI: 10.3892/etm.2022.11290Taquet M., Dercon Q., Luciano S., Geddes J.R. et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. DOI: 10.1371/journal.pmed.1003773Taquet M., Dercon Q., Luciano S., Geddes J.R. et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. DOI: 10.1371/journal.pmed.1003773Rousseau A.-F., Minguet P., Colson C., Kellens I. et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann. Intensive Care. 2021;11(1):118. DOI: 10.1186/s13613-021-00910-9Rousseau A.-F., Minguet P., Colson C., Kellens I. et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann. Intensive Care. 2021;11(1):118. DOI: 10.1186/s13613-021-00910-9Wu K.K., Lee D., Sze A.M., Ng V.N. et al. Posttraumatic stress, anxiety, and depression in COVID-19 survivors. East Asian Arch. Psychiatry. 2022;32(1):5–10. DOI: 10.12809/eaap2176Wu K.K., Lee D., Sze A.M., Ng V.N. et al. Posttraumatic stress, anxiety, and depression in COVID-19 survivors. East Asian Arch. Psychiatry. 2022;32(1):5–10. DOI: 10.12809/eaap2176Logue J.K., Franko N.M., McCulloch D.J., McDonald D. et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4(2):e210830. DOI: 10.1001/jamanetworkopen.2021.0830Logue J.K., Franko N.M., McCulloch D.J., McDonald D. et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4(2):e210830. DOI: 10.1001/jamanetworkopen.2021.0830Vanderlind W.M., Rabinovitz B.B., Miao I.Y., Oberlin L.E. et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr. Opin. Psychiatry. 2021;34(4):420–33. DOI: 10.1097/YCO.0000000000000713Vanderlind W.M., Rabinovitz B.B., Miao I.Y., Oberlin L.E. et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr. Opin. Psychiatry. 2021;34(4):420–33. DOI: 10.1097/YCO.0000000000000713Вертоградова О.П., Диков С.Ю. Соматовегетативные нарушения при разных типах депрессии. Журнал неврологии и психиатрии им. C.C. Корсакова. 2011;111(7):18–24.Vertogradova O.P., Dikov S.Yu. Somatic-autonomic disturbances in different types of depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(7):18–24. (in Russian)Bisaccia G., Ricci F., Recce V., Serio A. et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J. Cardiovasc. Dev. Dis. 2021;8(11):156. DOI: 10.3390/jcdd8110156Bisaccia G., Ricci F., Recce V., Serio A. et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J. Cardiovasc. Dev. Dis. 2021;8(11):156. DOI: 10.3390/jcdd8110156Shimohata T. Neuro-COVID-19. Clin. Exp. Neuroimmunol. 2022;13(1):17–23. DOI: 10.1111/cen3.12676Shimohata T. Neuro-COVID-19. Clin. Exp. Neuroimmunol. 2022;13(1):17–23. DOI: 10.1111/cen3.12676Сиволап Ю.П. Паническое расстройство: клинические феномены и возможности терапии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017;117(4):112–16. DOI: 10.17116/jnevro20171174112-116Sivolap Yu.P. Panic disorder: clinical phenomena and treatment options. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):112–16. (in Russian). DOI: 10.17116/jnevro20171174112-116Сорокин С.А. Апатические расстройства в структуре эндогенной депрессии. Психиатрия. 2015;1:33–8.Sorokin S.A. Apathetic disorders in the structure of endogenous depression. Psychiatry. 2015;1:33–8. (in Russian)Смулевич А.Б. Маскированные депрессии. Психические расстройства в общей медицине. 2012;3:4–7.Smulevich A.B. Masked depressions. Mental Disorders in General Medicine. 2012;3:4–7. (in Russian)Смулевич А.Б., Дубницкая Э.Б. Депрессии в общемедицинской сети. В кн.: Смулевич А.Б., ред. Психические расстройства в клинической практике. М.: МЕДпресс-информ; 2011: 334–60.Smulevich A.B., Dubnitskaya E.B. Depression in the general medical network. In: Smulevich A.B., ed. Mental disorders in clinical practice. M.: MEDpress-inform; 2011: 334–60. (in Russian)

The authors declare that there are no conflicts of interest present.